cblc137 and Trypanosomiasis--African

cblc137 has been researched along with Trypanosomiasis--African* in 1 studies

Other Studies

1 other study(ies) available for cblc137 and Trypanosomiasis--African

ArticleYear
Physiologic Targets and Modes of Action for CBL0137, a Lead for Human African Trypanosomiasis Drug Development.
    Molecular pharmacology, 2022, Volume: 102, Issue:1

    CBL0137 is a lead drug for human African trypanosomiasis, caused by

    Topics: Animals; Carbazoles; Drug Development; Humans; Trypanosoma brucei brucei; Trypanosomiasis, African

2022